Financhill
Back

Sage Therapeutics Stock Predictions

Sage Therapeutics Stock Forecast

  • Is Sage Therapeutics Stock Undervalued?
    The current Sage Therapeutics [SAGE] share price is $4.91. The Score for SAGE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

Data Unavailable

Sage Therapeutics Stock Rating

Data Unavailable

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com

52-Week Data

52-Week High:
28.26
52-Week Low:
4.74

Prediction Charts

Market Cap:
300.36M
Price in USD:
4.91
Volume:
1.58M
Beta:
1.36

Technical Analysis

SMA50:
6.81
SMA100:
8.22
SMA200:
12.15
52-Wk Change:
-75.1%

Stock Predictions

  • Is Sage Therapeutics stock public?
    Yes, Sage Therapeutics is a publicly traded company.
  • What is the Sage Therapeutics stock quote today?
    The Sage Therapeutics stock price is 4.91 USD today.
  • How to buy Sage Therapeutics stock online?
    You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 6.09 6.05 6.16 5.84
Nov-4 5.92 5.81 6.12 5.80
Nov-5 5.67 5.94 5.95 5.64
Nov-6 6.27 5.95 6.44 5.93
Nov-7 5.96 6.32 6.42 5.86
Nov-8 6.33 6.31 6.39 6.17
Nov-11 6.46 6.31 6.65 6.29
Nov-12 6.23 5.73 6.28 5.73
Nov-13 5.71 5.74 5.86 5.63
Nov-14 5.87 5.37 5.87 5.34
Nov-15 5.44 5.10 5.44 5.03
Nov-18 5.06 4.78 5.09 4.74
Nov-19 4.74 4.91 4.95 4.70
Nov-20 4.75 4.91 5.13 4.62

Sage Therapeutics Earnings

Data Unavailable

Sage Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.10 per share, and an increase next year of $2.36 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.